The B-cell antigen receptor integrates adaptive and innate immune signals

被引:31
|
作者
Otipoby, Kevin L. [1 ]
Waisman, Ari [2 ]
Derudder, Emmanuel [1 ,3 ]
Srinivasan, Lakshmi [1 ]
Franklin, Andrew [3 ]
Rajewsky, Klaus [1 ,2 ,3 ]
机构
[1] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA
[2] Univ Cologne, Inst Genet, D-50674 Cologne, Germany
[3] Max Delbruck Ctr Mol Med, Lab Immune Regulat & Canc, D-13125 Berlin, Germany
基金
欧盟地平线“2020”; 欧洲研究理事会; 美国国家卫生研究院;
关键词
BCR; B-cell proliferation; PI-3K; GSK3; beta; Foxo1; MOUSE IMMUNOGLOBULIN ANTIBODIES; LYMPHOCYTE DEVELOPMENT; KAPPA-B; GENE; ACTIVATION; KINASE; EXPRESSION; RESPONSES; SURVIVAL; PATHWAY;
D O I
10.1073/pnas.1516428112
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
B cells respond to antigens by engagement of their B-cell antigen receptor (BCR) and of coreceptors through which signals from helper T cells or pathogen-associated molecular patterns are delivered. We show that the proliferative response of B cells to the latter stimuli is controlled by BCR-dependent activation of phosphoinositidyl 3-kinase (PI-3K) signaling. Glycogen synthase kinase 3 beta and Foxo1 are two PI-3K-regulated targets that play important roles, but to different extents, depending on the specific mitogen. These results suggest a model for integrating signals from the innate and the adaptive immune systems in the control of the B-cell immune response.
引用
收藏
页码:12145 / 12150
页数:6
相关论文
共 50 条
  • [31] B-cell antigen receptor-induced apoptosis: looking for clues
    Eldering, E
    vanLier, RAW
    IMMUNOLOGY LETTERS, 2005, 96 (02) : 187 - 194
  • [32] Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    Svoboda, Jakub
    Chong, Elise A.
    Nasta, Sunita D.
    Mato, Anthony R.
    Anak, Ozlem
    Brogdon, Jennifer L.
    Pruteanu-Malinici, Iulian
    Bhoj, Vijay
    Landsburg, Daniel
    Wasik, Mariusz
    Levine, Bruce L.
    Lacey, Simon F.
    Melenhorst, Jan J.
    Porter, David L.
    June, Carl H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26) : 2545 - 2554
  • [33] Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma
    Meriranta, Leo
    Sorri, Selma
    Huse, Kanutte
    Liu, Xiaonan
    Spasevska, Ivana
    Zafar, Sadia
    Chowdhury, Iftekhar
    Dufva, Olli
    Sahlberg, Eerika
    Tandaric, Luka
    Karjalainen-Lindsberg, Marja-Liisa
    Hyytiainen, Marko
    Varjosalo, Markku
    Myklebust, June H.
    Leppa, Sirpa
    BLOOD CANCER DISCOVERY, 2024, 5 (05): : 331 - 352
  • [34] SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
    Chen, Linfeng
    Monti, Stefano
    Juszczynski, Przemyslaw
    Daley, John
    Chen, Wen
    Witzig, Thomas E.
    Habermann, Thomas M.
    Kutok, Jeffery L.
    Shipp, Margaret A.
    BLOOD, 2008, 111 (04) : 2230 - 2237
  • [35] B-cell intrinsic and extrinsic signals that regulate central tolerance of mouse and human B cells*
    Pelanda, Roberta
    Greaves, Sarah A.
    da Costa, Thiago Alves
    Cedrone, Lena M.
    Campbell, Margaret L.
    Torres, Raul M.
    IMMUNOLOGICAL REVIEWS, 2022, 307 (01) : 12 - 26
  • [36] B-cell receptor signal strength influences terminal differentiation
    Lechouane, Fabien
    Bonaud, Amelie
    Delpy, Laurent
    Casola, Stefano
    Oruc, Zeliha
    Chemin, Guillaume
    Cogne, Michel
    Sirac, Christophe
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (03) : 619 - 628
  • [37] Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma
    Belting, Lena
    Hoemberg, Nadine
    Przewoznik, Margarethe
    Brenner, Christoph
    Riedel, Tanja
    Flatley, Andrew
    Polic, Bojan
    Busch, Dirk H.
    Roecken, Martin
    Mocikat, Ralph
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (09) : 2593 - 2601
  • [38] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Hamilton, Mark P.
    Miklos, David B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
  • [39] Effect of Antigen Valency on Autoreactive B-Cell Targeting
    van Weijsten, M. J.
    Venrooij, K. R.
    Lelieveldt, L. P. W. M.
    Kissel, T.
    van Buijtenen, E.
    van Dalen, F. J.
    Verdoes, M.
    Toes, R. E. M.
    Bonger, K. M.
    MOLECULAR PHARMACEUTICS, 2023, 21 (02) : 481 - 490
  • [40] B-cell maturation antigen directed monoclonal antibody therapies for multiple myeloma
    Eckhert, Erik
    Hewitt, Rhonda
    Liedtke, Michaela
    IMMUNOTHERAPY, 2019, 11 (09) : 801 - 811